NASDAQ:NTRA
Natera (NTRA)
Financials 
Technical Analysis 
Aug 14, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Natera (NTRA-Q) has garnered significant attention following a strong earnings report, surpassing expectations and providing an optimistic outlook for future growth. The company's flagship disease test has shown impressive performance, positioning it at the forefront of its market with an expansive total addressable market estimated at $7 billion. This remarkable achievement highlights Natera's competitive advantage and leadership in the sector, supported by a strong management team that is focused on innovation and strategic growth. Experts express a bullish sentiment regarding the company's prospects, underlining its potential for continued success and market dominance in the health diagnostics arena.
- «
- ‹
- 1
- ›
- »
Popular Articles
Natera (NTRA) Frequently Asked Questions
What is Natera stock symbol?
Natera is a American stock, trading under the symbol NTRA (previously NTRA-Q on Stockchase) on the NASDAQ (NTRA). It is usually referred to as NASDAQ:NTRA or NTRA
Is Natera a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on NTRA (previously NTRA-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Natera.
Is Natera a good investment or a top pick?
Natera was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Natera.
Why is Natera stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Natera.
Is Natera worth watching?
Natera is followed by 9 investors on Stockchase and is a trending stock that is worth watching.
What is Natera stock price?
On 2026-08-13, Natera (NTRA) stock closed at a price of $310.78.
Is soaring on earnings: they beat and raise. Their signature disease test outperformed and boasts a total addressable market of $7 billion. They are tops in this space. Great managers.